Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Phase II Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

NCT02555410 is registered in ClinicalTrials.gov with Brain Sentinel as lead sponsor.

NCT NCT02555410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Phase II Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Lead sponsor
Brain Sentinel
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
July 7, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, generalized tonic-clonic seizures